Abstract
Objectives
To determine the incidence of Ureaplasma urealyticum and Ureaplasma parvum (UP) in symptomatic and asymptomatic women of reproductive age and to estimate antibiotic susceptibility of ureaplasma isolates.
Materials and methods
This study included 424 ureaplasma positive women of 1,370 tested women who visited gynecological practices during 2010. Cervicovaginal or urethral swab specimens from each patient were obtained for cultivation and molecular typing by RT-PCR.
Results
Ureaplasma spp. was identified by cultivation in 424 (34.4 %) cases, of which 79.0 % were from women with symptoms and 21.0 % from women without symptoms. Among ureaplasma positive women, 121 (28.5 %) were pregnant. Genotyping was successful in 244 strains, and the majority of samples were identified as UP (92.6 %). Among genotyped isolates, there were 79.5 % from symptomatic and 20.5 % from asymptomatic women; 29.9 % from pregnant and 70.1 % from non-pregnant women. There was no difference in the incidence of ureaplasma type regarding symptoms. Antibiotic susceptibility of 424 ureaplasma isolates identified by cultivation showed that all strains were susceptible to doxycycline, josamycin, erythromycin, tetracycline, clarithromycin and pristinamycin, but there was lower susceptibility to quinolone antibiotics, i.e., 42.9 and 24.5 % isolates were susceptible to ofloxacin and ciprofloxacin, respectively.
Conclusion
This study shows that UP was the most frequent isolated ureaplasma species (92.6 %). Regarding antibiotic susceptibility, quinolones are not the best choice for the treatment of ureaplasma infections, while macrolides and tetracyclines are still effective.
Similar content being viewed by others
References
Waites KB, Taylor-Robinson D (2011) Mycoplasma and ureaplasma. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML (eds) Manual of clinical microbiology, 10th edn. ASM Press, Washington DC, pp 974–985
Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R (1993) Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 6:69–87
Waites KB, Katz B, Schelonka RL (2005) Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 18:757–789. doi:10.1128/CMR.18.4.757-789.2005
Taylor-Robinson D, Bébéar C (1997) Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother 40:622–630. doi:10.1093/jac/40.5.622
Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY et al (2000) The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature 407:757–762. doi:10.1038/35037619
Zhang W, Wu Y, Yin W, Yu M (2002) Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites. Chin Med J 115:1573–1575
Daxboeck F, Zitta S, Stadler M, Iro E, Krause R (2005) Mycoplasma hominis and Ureaplasma urealyticum in patients with sterile pyuria. J Infect 51:54–58. doi:10.1016/j.jinf.2004.06.010
Witt A, Berger A, Gruber CJ, Petricevic L, Apfalter P et al (2005) Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol 193:1663–1669. doi:10.1016/j.ajog.2005.03.067
Pararas MV, Skevaki CL, Kafetzis DA (2006) Preterm birth due to maternal infection: causative pathogens and modes of prevention. Eur J Clin Microbiol Infect Dis 25:562–569. doi:10.1007/s10096-006-0190-3
Clegg A, Passey M, Yoannes M, Michael A (1997) High rates of genital mycoplasma infection in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J Clin Microbiol 35:197–200
Robertson JA, Stemke GW, Davis JW, Harasawa R, Thirkell D et al (2002) Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol 52:587–597
Mallard K, Schopfer K, Bodmer T (2005) Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum. J Microbiol Methods 60:13–19. doi:10.1016/j.mimet.2004.08.005
Kilic D, Basar MM, Kaygusuz S, Yilmaz E, Basar H et al (2004) Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis. Jpn J Infect Dis 57:17–20
Xie X, Zhang J (2006) Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. FEMS Microbiol Lett 259:181–186. doi:10.1111/j.1574-6968.2006.00239.x
Airell A, Ottosson L, Bygdeman SM, Carlberg H, Lidbrink P et al (2000) Chlamydia trachomatis PCR (Cobas Amplicor) in women: endocervical specimen transported in a specimen of urine versus endocervical and urethral specimens in 2-SP medium versus urine specimen only. Int J STD AIDS 11:651–658
Zdrodowska-Stefanow B, Kłosowska WM, Ostaszewska-Puchalska I, Bułhak-Kozioł V, Kotowicz B (2006) Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. Adv Med Sci 51:250–253
Kechagia N, Bersimis S, Chatzipanagiotou S (2008) Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J Antimicrob Chemother 62:122–125. doi:10.1093/jac/dkn158
Ekiel AM, Friedek DA, Romanik MK, Jóźwiak J, Martirosian G (2009) Occurrence of Ureaplasma parvum and Ureaplasma urealyticum in women with cervical dysplasia in Katowice, Poland. J Korean Med Sci 24:1177–1181. doi:10.3346/jkms.2009.24.6.1177
Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH et al (2010) Detection and characterization of human ureaplasma species and serovars by real-time PCR. J Clin Microbiol 48:2715–2723. doi:10.1128/JCM.01877-09
Tang J, Zhou L, Liu X, Zhang C, Zhao Y et al (2011) Novel multiplex real-time PCR system using the SNP technology for the simultaneous diagnosis of Chlamydia trachomatis, Ureaplasma parvum and Ureaplasma urealyticum and genetic typing of serovars of C. trachomatis and U. parvum in NGU. Mol Cell Probes 25:55–59. doi:10.1016/j.mcp.2010.12.001
Kacerovský M, Boudys L (2008) Preterm premature rupture of membranes and Ureaplasma urealyticum. Ceska Gynekol 73:154–159
Beeton ML, Chalker VJ, Kotecha S, Spiller OB (2009) Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. J Antimicrob Chemother 64:529–538. doi:10.1093/jac/dkp218
Bayraktar MR, Ozerol IH, Gucluer N, Celik O (2010) Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis 14:e90–e95. doi:10.1016/j.ijid.2009.03.020
Govender S, Theron GB, Odendaal HJ, Chalkley LJ (2009) Prevalence of genital mycoplasmas, ureaplasmas and chlamydia in pregnancy. J Obstet Gynaecol 29:698–701. doi:10.3109/01443610903184033
Vogel I, Thorsen P, Hogan VK, Schieve LA, Jacobsson B et al (2006) The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes. Acta Obstet Gynecol Scand 85:778–785. doi:10.1080/00016340500442423
Mareş MNV (2011) High prevalence of fluoroquinolones resistance in Ureaplasma and Mycoplasma strains isolated from infertile women under initial evaluation in North-east Romania. Romanian Biotechnol Lett 16:5858–5862
Acknowledgments
Authors thank Dr Irena Tabain for technical assistance, Dr Štefica Findri-Guštek and Dr Jean Chedid for sample collection. This research has been partially supported by the Ministry of Science, Education and Sports (Grant Number: 098-0982464-2510).
Conflict of interest
The authors have declared that no competing interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hunjak, B., Sabol, I., Vojnović, G. et al. Ureaplasma urealyticum and Ureaplasma parvum in women of reproductive age. Arch Gynecol Obstet 289, 407–412 (2014). https://doi.org/10.1007/s00404-013-2980-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-013-2980-z